Tauopathies Treatment
Tauopathies Treatment market is segmented by region (country), players, by Type and by Applicatio ... Read More
Global and United States Follicular Lymphoma Treatment Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Follicular Lymphoma Treatment Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Follicular Lymphoma Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Follicular Lymphoma Treatment Market Size for the Year 2017-2028
1.2.2 Global Follicular Lymphoma Treatment Market Size for the Year 2017-2028
1.3 Follicular Lymphoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Follicular Lymphoma Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Follicular Lymphoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Follicular Lymphoma Treatment Market Dynamics
1.4.1 Follicular Lymphoma Treatment Industry Trends
1.4.2 Follicular Lymphoma Treatment Market Drivers
1.4.3 Follicular Lymphoma Treatment Market Challenges
1.4.4 Follicular Lymphoma Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Follicular Lymphoma Treatment by Type
2.1 Follicular Lymphoma Treatment Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Radiotherapy
2.1.3 Monoclonal Antibodies
2.1.4 Stem Cell Transplantation
2.2 Global Follicular Lymphoma Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Follicular Lymphoma Treatment Market Size by Type (2017-2028)
2.4 United States Follicular Lymphoma Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Follicular Lymphoma Treatment Market Size by Type (2017-2028)
3 Follicular Lymphoma Treatment by Application
3.1 Follicular Lymphoma Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Follicular Lymphoma Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Follicular Lymphoma Treatment Market Size by Application (2017-2028)
3.4 United States Follicular Lymphoma Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Follicular Lymphoma Treatment Market Size by Application (2017-2028)
4 Global Follicular Lymphoma Treatment Competitor Landscape by Company
4.1 Global Follicular Lymphoma Treatment Market Size by Company
4.1.1 Top Global Follicular Lymphoma Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Follicular Lymphoma Treatment Revenue by Player (2017-2022)
4.2 Global Follicular Lymphoma Treatment Concentration Ratio (CR)
4.2.1 Follicular Lymphoma Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Follicular Lymphoma Treatment in 2021
4.2.3 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Follicular Lymphoma Treatment Headquarters, Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Follicular Lymphoma Treatment Headquarters and Area Served
4.3.2 Global Follicular Lymphoma Treatment Companies Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Follicular Lymphoma Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Follicular Lymphoma Treatment Market Size by Company
4.5.1 Top Follicular Lymphoma Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Follicular Lymphoma Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Follicular Lymphoma Treatment Market Size by Region
5.1 Global Follicular Lymphoma Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Follicular Lymphoma Treatment Market Size by Region (2017-2028)
5.2.1 Global Follicular Lymphoma Treatment Market Size by Region: 2017-2022
5.2.2 Global Follicular Lymphoma Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Follicular Lymphoma Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Follicular Lymphoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Follicular Lymphoma Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Follicular Lymphoma Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Follicular Lymphoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Follicular Lymphoma Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Follicular Lymphoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Follicular Lymphoma Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Follicular Lymphoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Details
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
7.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.1.5 Boehringer Ingelheim GmbH Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Details
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
7.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Celgene Corporation
7.3.1 Celgene Corporation Company Details
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
7.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.3.5 Celgene Corporation Recent Development
7.4 Celldex Therapeutics, Inc.
7.4.1 Celldex Therapeutics, Inc. Company Details
7.4.2 Celldex Therapeutics, Inc. Business Overview
7.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
7.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.4.5 Celldex Therapeutics, Inc. Recent Development
7.5 Celltrion, Inc.
7.5.1 Celltrion, Inc. Company Details
7.5.2 Celltrion, Inc. Business Overview
7.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
7.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.5.5 Celltrion, Inc. Recent Development
7.6 Cellular Biomedicine Group, Inc.
7.6.1 Cellular Biomedicine Group, Inc. Company Details
7.6.2 Cellular Biomedicine Group, Inc. Business Overview
7.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
7.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.6.5 Cellular Biomedicine Group, Inc. Recent Development
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Company Details
7.7.2 Coherus BioSciences, Inc. Business Overview
7.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
7.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.7.5 Coherus BioSciences, Inc. Recent Development
7.8 CTI BioPharma Corp.
7.8.1 CTI BioPharma Corp. Company Details
7.8.2 CTI BioPharma Corp. Business Overview
7.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
7.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.8.5 CTI BioPharma Corp. Recent Development
7.9 Curis, Inc.
7.9.1 Curis, Inc. Company Details
7.9.2 Curis, Inc. Business Overview
7.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
7.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.9.5 Curis, Inc. Recent Development
7.10 Dynavax Technologies Corporation
7.10.1 Dynavax Technologies Corporation Company Details
7.10.2 Dynavax Technologies Corporation Business Overview
7.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
7.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.10.5 Dynavax Technologies Corporation Recent Development
7.11 Eisai
7.11.1 Eisai Company Details
7.11.2 Eisai Business Overview
7.11.3 Eisai Follicular Lymphoma Treatment Introduction
7.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.11.5 Eisai Recent Development
7.12 EpiZyme, Inc.
7.12.1 EpiZyme, Inc. Company Details
7.12.2 EpiZyme, Inc. Business Overview
7.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
7.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.12.5 EpiZyme, Inc. Recent Development
7.13 F. Hoffmann-La Roche Ltd.
7.13.1 F. Hoffmann-La Roche Ltd. Company Details
7.13.2 F. Hoffmann-La Roche Ltd. Business Overview
7.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
7.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.13.5 F. Hoffmann-La Roche Ltd. Recent Development
7.14 Genentech, Inc.
7.14.1 Genentech, Inc. Company Details
7.14.2 Genentech, Inc. Business Overview
7.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
7.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.14.5 Genentech, Inc. Recent Development
7.15 Gilead Sciences, Inc.
7.15.1 Gilead Sciences, Inc. Company Details
7.15.2 Gilead Sciences, Inc. Business Overview
7.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
7.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.15.5 Gilead Sciences, Inc. Recent Development
7.16 GlaxoSmithKline Plc
7.16.1 GlaxoSmithKline Plc Company Details
7.16.2 GlaxoSmithKline Plc Business Overview
7.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
7.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.16.5 GlaxoSmithKline Plc Recent Development
7.17 Hutchison MediPharma Limited
7.17.1 Hutchison MediPharma Limited Company Details
7.17.2 Hutchison MediPharma Limited Business Overview
7.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
7.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.17.5 Hutchison MediPharma Limited Recent Development
7.18 Immune Design Corp.
7.18.1 Immune Design Corp. Company Details
7.18.2 Immune Design Corp. Business Overview
7.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
7.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.18.5 Immune Design Corp. Recent Development
7.19 ImmunoGen, Inc.
7.19.1 ImmunoGen, Inc. Company Details
7.19.2 ImmunoGen, Inc. Business Overview
7.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
7.19.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022)
7.19.5 ImmunoGen, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Follicular Lymphoma Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Follicular Lymphoma Treatment Market Trends
Table 3. Follicular Lymphoma Treatment Market Drivers
Table 4. Follicular Lymphoma Treatment Market Challenges
Table 5. Follicular Lymphoma Treatment Market Restraints
Table 6. Global Follicular Lymphoma Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Follicular Lymphoma Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Follicular Lymphoma Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Follicular Lymphoma Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Follicular Lymphoma Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Follicular Lymphoma Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Follicular Lymphoma Treatment Revenue Share by Player, 2017-2022
Table 13. Global Follicular Lymphoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Follicular Lymphoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Treatment as of 2021)
Table 15. Top Players of Follicular Lymphoma Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Follicular Lymphoma Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Follicular Lymphoma Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Follicular Lymphoma Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Follicular Lymphoma Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Follicular Lymphoma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Follicular Lymphoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Follicular Lymphoma Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Follicular Lymphoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Follicular Lymphoma Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Follicular Lymphoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Follicular Lymphoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Follicular Lymphoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Boehringer Ingelheim GmbH Company Details
Table 31. Boehringer Ingelheim GmbH Business Overview
Table 32. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product
Table 33. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 34. Boehringer Ingelheim GmbH Recent Development
Table 35. Bristol-Myers Squibb Company Company Details
Table 36. Bristol-Myers Squibb Company Business Overview
Table 37. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product
Table 38. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 39. Bristol-Myers Squibb Company Recent Development
Table 40. Celgene Corporation Company Details
Table 41. Celgene Corporation Business Overview
Table 42. Celgene Corporation Follicular Lymphoma Treatment Product
Table 43. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 44. Celgene Corporation Recent Development
Table 45. Celldex Therapeutics, Inc. Company Details
Table 46. Celldex Therapeutics, Inc. Business Overview
Table 47. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product
Table 48. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 49. Celldex Therapeutics, Inc. Recent Development
Table 50. Celltrion, Inc. Company Details
Table 51. Celltrion, Inc. Business Overview
Table 52. Celltrion, Inc. Follicular Lymphoma Treatment Product
Table 53. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 54. Celltrion, Inc. Recent Development
Table 55. Cellular Biomedicine Group, Inc. Company Details
Table 56. Cellular Biomedicine Group, Inc. Business Overview
Table 57. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product
Table 58. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 59. Cellular Biomedicine Group, Inc. Recent Development
Table 60. Coherus BioSciences, Inc. Company Details
Table 61. Coherus BioSciences, Inc. Business Overview
Table 62. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product
Table 63. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 64. Coherus BioSciences, Inc. Recent Development
Table 65. CTI BioPharma Corp. Company Details
Table 66. CTI BioPharma Corp. Business Overview
Table 67. CTI BioPharma Corp. Follicular Lymphoma Treatment Product
Table 68. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 69. CTI BioPharma Corp. Recent Development
Table 70. Curis, Inc. Company Details
Table 71. Curis, Inc. Business Overview
Table 72. Curis, Inc. Follicular Lymphoma Treatment Product
Table 73. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 74. Curis, Inc. Recent Development
Table 75. Dynavax Technologies Corporation Company Details
Table 76. Dynavax Technologies Corporation Business Overview
Table 77. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product
Table 78. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 79. Dynavax Technologies Corporation Recent Development
Table 80. Eisai Company Details
Table 81. Eisai Business Overview
Table 82. Eisai Follicular Lymphoma Treatment Product
Table 83. Eisai Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 84. Eisai Recent Development
Table 85. EpiZyme, Inc. Company Details
Table 86. EpiZyme, Inc. Business Overview
Table 87. EpiZyme, Inc. Follicular Lymphoma Treatment Product
Table 88. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 89. EpiZyme, Inc. Recent Development
Table 90. F. Hoffmann-La Roche Ltd. Company Details
Table 91. F. Hoffmann-La Roche Ltd. Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product
Table 93. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 94. F. Hoffmann-La Roche Ltd. Recent Development
Table 95. Genentech, Inc. Company Details
Table 96. Genentech, Inc. Business Overview
Table 97. Genentech, Inc. Follicular Lymphoma Treatment Product
Table 98. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 99. Genentech, Inc. Recent Development
Table 100. Gilead Sciences, Inc. Company Details
Table 101. Gilead Sciences, Inc. Business Overview
Table 102. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product
Table 103. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 104. Gilead Sciences, Inc. Recent Development
Table 105. GlaxoSmithKline Plc Company Details
Table 106. GlaxoSmithKline Plc Business Overview
Table 107. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product
Table 108. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 109. GlaxoSmithKline Plc Recent Development
Table 110. Hutchison MediPharma Limited Company Details
Table 111. Hutchison MediPharma Limited Business Overview
Table 112. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product
Table 113. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 114. Hutchison MediPharma Limited Recent Development
Table 115. Immune Design Corp. Company Details
Table 116. Immune Design Corp. Business Overview
Table 117. Immune Design Corp. Follicular Lymphoma Treatment Product
Table 118. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 119. Immune Design Corp. Recent Development
Table 120. ImmunoGen, Inc. Company Details
Table 121. ImmunoGen, Inc. Business Overview
Table 122. ImmunoGen, Inc. Follicular Lymphoma Treatment Product
Table 123. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2017-2022) & (US$ Million)
Table 124. ImmunoGen, Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicular Lymphoma Treatment Product Picture
Figure 2. Global Follicular Lymphoma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Follicular Lymphoma Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Follicular Lymphoma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Follicular Lymphoma Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Follicular Lymphoma Treatment Market Share in Global 2017-2028
Figure 7. Follicular Lymphoma Treatment Report Years Considered
Figure 8. Product Picture of Chemotherapy
Figure 9. Product Picture of Radiotherapy
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Product Picture of Stem Cell Transplantation
Figure 12. Global Follicular Lymphoma Treatment Market Share by Type in 2022 & 2028
Figure 13. Global Follicular Lymphoma Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Follicular Lymphoma Treatment Market Share by Type (2017-2028)
Figure 15. United States Follicular Lymphoma Treatment Market Share by Type in 2022 & 2028
Figure 16. United States Follicular Lymphoma Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Follicular Lymphoma Treatment Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Follicular Lymphoma Treatment Market Share by Application in 2022 & 2028
Figure 22. Global Follicular Lymphoma Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Follicular Lymphoma Treatment Market Share by Application (2017-2028)
Figure 24. United States Follicular Lymphoma Treatment Market Share by Application in 2022 & 2028
Figure 25. United States Follicular Lymphoma Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Follicular Lymphoma Treatment Market Share by Application (2017-2028)
Figure 27. North America Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Follicular Lymphoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Boehringer Ingelheim GmbH Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 57. Celgene Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 58. Celldex Therapeutics, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 59. Celltrion, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 60. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 61. Coherus BioSciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 62. CTI BioPharma Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 63. Curis, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 64. Dynavax Technologies Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 65. Eisai Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 66. EpiZyme, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 67. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 68. Genentech, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 69. Gilead Sciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 70. GlaxoSmithKline Plc Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 71. Hutchison MediPharma Limited Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 72. Immune Design Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 73. ImmunoGen, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Celgene Corporation Celldex Therapeutics, Inc. Celltrion, Inc. Cellular Biomedicine Group, Inc. Coherus BioSciences, Inc. CTI BioPharma Corp. Curis, Inc. Dynavax Technologies Corporation Eisai EpiZyme, Inc. F. Hoffmann-La Roche Ltd. Genentech, Inc. Gilead Sciences, Inc. GlaxoSmithKline Plc Hutchison MediPharma Limited Immune Design Corp. ImmunoGen, Inc.